Intra-Cellular Therapies Inc. - Common Stock (ITCI)
127.07
+0.07 (0.06%)
Intra-Cellular Therapeutics is a biopharmaceutical company focused on the development of innovative therapies for neuropsychiatric and neurological disorders
The company aims to address unmet medical needs by exploring the underlying mechanisms of cellular signaling and neurotransmission. Its research encompasses a range of conditions, including schizophrenia, mood disorders, and neurodegenerative diseases, leveraging advanced science and technology to create novel treatment options that have the potential to improve the quality of life for patients.
Frequently Asked Questions
Is Intra-Cellular Therapies Inc. - Common Stock publicly traded?
Yes, Intra-Cellular Therapies Inc. - Common Stock is publicly traded.
What exchange does Intra-Cellular Therapies Inc. - Common Stock trade on?
Intra-Cellular Therapies Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intra-Cellular Therapies Inc. - Common Stock?
The ticker symbol for Intra-Cellular Therapies Inc. - Common Stock is ITCI on the Nasdaq Stock Market
What is the current price of Intra-Cellular Therapies Inc. - Common Stock?
The current price of Intra-Cellular Therapies Inc. - Common Stock is 127.07
When was Intra-Cellular Therapies Inc. - Common Stock last traded?
The last trade of Intra-Cellular Therapies Inc. - Common Stock was at 9:39 am EST on January 31st, 2025
What is the market capitalization of Intra-Cellular Therapies Inc. - Common Stock?
The market capitalization of Intra-Cellular Therapies Inc. - Common Stock is 11.99B
How many shares of Intra-Cellular Therapies Inc. - Common Stock are outstanding?
Intra-Cellular Therapies Inc. - Common Stock has 94.32M shares outstanding.